These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials. Dische S, Saunders MI, Flockhart IR. Br J Cancer Suppl; 1978 Jun; 3():318-21. PubMed ID: 209811 [Abstract] [Full Text] [Related]
3. Prolonged metronidazole administration with protracted radiotherapy: a pilot study on response of advanced tumours. Karim AB. Br J Cancer Suppl; 1978 Jun; 3():299-301. PubMed ID: 277249 [Abstract] [Full Text] [Related]
4. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Sheldon PW, Fowler JF. Br J Cancer Suppl; 1978 Jun; 3():242-5. PubMed ID: 277239 [Abstract] [Full Text] [Related]
11. The response of human tumour metastases to radiation and misonidazole. Dawen PJ, Peckham MJ, Steel GG. Br J Cancer Suppl; 1978 Jun; 3():290-6. PubMed ID: 277247 [Abstract] [Full Text] [Related]
12. Clinical objectives and normal tissue responses in combined chemotherapy and radiotherapy. Peckham MJ, Collis CH. Bull Cancer; 1981 Jun; 68(2):132-41. PubMed ID: 7236899 [Abstract] [Full Text] [Related]
13. Misonidazole in the preoperative and radical radiotherapy of bladder cancer. Awwad HK, El Merzabani MM, El Badawy S, Ezzat S, Akoush H, Abd El Moneim H, Saiid A, Soliman O, Khafagy M, Burgers MV. Cancer Clin Trials; 1980 Jun; 3(3):275-80. PubMed ID: 7438324 [Abstract] [Full Text] [Related]